
IndraLab
Statements
Pyrimidine inhibits JAK1. 2 / 2
|
2
reach
"Additionally, the pyrazolyl pyrimidine AZD1480, which potently inhibits JAK1 (IC 50 value of 1.3 nM) and JAK2 (IC 50 value of 0.4 nM) 186, differentially suppressed STAT1, STAT3, STAT5 and STAT6 activation at 0.1-5 muM concentration in prostate, ovarian, glioma, and breast cancer cells in vitro XREF_BIBR, XREF_BIBR."